Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Singh, Vijay Kumar; Werner, Sebastian; Schwalm, Simone et al.
NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphomaONCOIMMUNOLOGY. 2019
Heinrich, Stefan; Besselink, Marc; Moehler, Markus et al.
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette studyBMC CANCER. Bd. 19. 2019
Dimopoulos, Meletios A.; Gay, Francesca; Schjesvold, Fredrik et al.
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trialLANCET. Bd. 393. H. 10168. 2019 S. 253-264
Buettner, Matthias; Koenig, Hans-Helmut; Loebner, Margrit et al.
Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal studySUPPORTIVE CARE IN CANCER. Bd. 27. H. 6. 2019 S. 2221-2228
Hasenburg, A.
Ovarian Cancer Recurrence: Antiangiogenesis delays ProgressionGYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionUntch, Harbeck, Thomssen (Hrsg). Colloquium Senologie 2019/2020. München: LUKON Verlagsgesellschaft mbH 2019
Ferrata, Martina; Schad, Arno; Zimmer, Stefanie et al.
PD-L1 Expression and Immune Cell In fi ltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative ActivityFRONTIERS IN ONCOLOGY. Bd. 9. 2019
Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia et al.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialLANCET. Bd. 393. H. 10184. 2019 S. 1948-1957
Papachristofilou, Alexandros; Hipp, Madeleine M.; Klinkhardt, Ute et al.
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerJOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 7. 2019
Ayuk, Francis; Bornhaeuser, Martin; Stelljes, Matthias et al.
Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) Are Associated with Poorer Outcome after Single Mismatch Unrelated Donor Stem Cell Transplantation: A Study of the Cooperative Transplant Study Group (KTS) of the German Group for Bone Marrow and Stem Cell Transplantation (DAG-KBT)TRANSFUSION MEDICINE AND HEMOTHERAPY. Bd. 46. H. 5. 2019 S. 370-375